The Critical Role of DIAD Research in Pre-Symptomatic Alzheimer’s Disease (Italian)

Description: A panel discussion on the role of DIAD research in increasing our understanding of and ability to detect pre-symptomatic Alzheimer’s disease
Runtime: 00:53:25

Speaker: Randall Bateman, MD
Speaker title: DIAN Trials Unit Director
Speaker organization: Washington University in St. Louis

Speaker: Rachelle Doody, MD, PhD
Speaker title: Global Head of Neurodegeneration
Speaker organization: Roche and Genentech

Speaker: Jason Hassenstab, PhD
Speaker title: Director, DIAN and DIAN-TU Cognition Cores
Speaker organization: Washington University in St. Louis

Speaker: Eric Siemers, MD
Speaker title: Distinguished Medical Fellow
Speaker organization: Eli Lilly

Speaker: Nick Cochran, PhD
Speaker title: Postdoctoral Fellow
Speaker organization: HudsonAlpha Institute for Biotechnology

Speaker: Gary Romano, MD
Speaker title: Head of Development, Alzheimer’s Disease and Neurology
Speaker organization: Janssen

Speaker: Pierre Tariot, MD
Speaker title: Co-Director
Speaker organization: Alzheimer’s Prevention Initiative

Event: 2017 DIAD Family Conference: Key to the Cure
Location: London, England, United Kingdom
Year: 2017

Search tags: preclinical Alzheimer’s, APOE4, clinical trials, DIAN-TU, primary prevention, privacy, genetic information, genetic status, research participation, regulation